ID   SNU-1544
AC   CVCL_5027
SY   SNU1544
DR   cancercelllines; CVCL_5027
DR   Cell_Model_Passport; SIDM01838
DR   ColonAtlas; SNU1544
DR   Cosmic; 1322292
DR   DepMap; ACH-001786
DR   GEO; GSM1448192
DR   IARC_TP53; 28480
DR   KCLB; 01544
DR   Wikidata; Q54955119
RX   PubMed=20176655;
RX   PubMed=25926053;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 42 hours (PubMed=20176655).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=20176655; PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; 583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Unspecified (PubMed=20176655).
CC   Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Unspecified (PubMed=20176655).
CC   Sequence variation: Mutation; HGNC; 7127; MLH1; Simple; p.Ser2Leu (c.5C>T); ClinVar=VCV000182533; Zygosity=Unspecified (PubMed=20176655).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; None_reported; -; Zygosity=- (PubMed=20176655).
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): DepMap=ACH-001786; KCLB=01544; PubMed=20176655; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 11,12 (KCLB=01544; PubMed=20176655; PubMed=25926053)
ST   CSF1PO: 11.1,12 (DepMap=ACH-001786)
ST   D13S317: 9,11
ST   D16S539: 8,14
ST   D18S51: 12,17
ST   D19S433: 14.2,16.2
ST   D21S11: 29,30
ST   D2S1338: 19
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 10
ST   FGA: 20,23,24 (DepMap=ACH-001786)
ST   FGA: 20,24 (PubMed=20176655)
ST   Penta D: 8,12
ST   Penta E: 9,16
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,19,20,21 (DepMap=ACH-001786)
ST   vWA: 14,20 (KCLB=01544; PubMed=20176655)
ST   vWA: 14,20,21 (PubMed=25926053)
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 24
//
RX   PubMed=20176655; DOI=10.1093/carcin/bgq043;
RA   Ku J.-L., Shin Y.-K., Kim D.-W., Kim K.-H., Choi J.-S., Hong S.-H.,
RA   Jeon Y.-K., Kim S.-H., Kim H.-S., Park J.-H., Kim I.-J., Park J.-G.;
RT   "Establishment and characterization of 13 human colorectal carcinoma
RT   cell lines: mutations of genes and expressions of drug-sensitivity
RT   genes and cancer stem cell markers.";
RL   Carcinogenesis 31:1003-1009(2010).
//
RX   PubMed=25926053; DOI=10.1038/ncomms8002;
RA   Medico E., Russo M., Picco G., Cancelliere C., Valtorta E., Corti G.,
RA   Buscarino M., Isella C., Lamba S., Martinoglio B., Veronese S.,
RA   Siena S., Sartore-Bianchi A., Beccuti M., Mottolese M.,
RA   Linnebacher M., Cordero F., Di Nicolantonio F., Bardelli A.;
RT   "The molecular landscape of colorectal cancer cell lines unveils
RT   clinically actionable kinase targets.";
RL   Nat. Commun. 6:7002.1-7002.10(2015).
//